PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 7, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the ...
11d
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jefferies, TD Cowen and Piper Sandler are acting as joint book-running managers for the offering. Wedbush PacGrow and LifeSci Capital are acting as passive bookrunners for this offering.
WEST PALM BEACH, FLORIDA / ACCESS Newswire / January / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of autonomous aerial and ground robot intelligence through its ...
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
REDWOOD CITY, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (JSPR) (“Jasper”), a clinical-stage biotechnology company focused on development of briquilimab, a novel antibody ...
HENDERSON, Nev., Oct. 9, 2025 /PRNewswire/ -- VolitionRx Limited (VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it is proposing to offer and sell, in ...
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that it intends ...
The filing relates to the sale or other disposition from time to time of (i) up to 21.66M shares of common stock issuable upon the exercise of ...
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten public offering of 9,142,857 shares of its common ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback